We are Eden Ltd

Last updated on

Visit website

NHS problem

Gynaecology and urology represent the fifth-largest elective specialty backlog in the NHS. This post-diagnostic, pre-treatment bottleneck leaves over 560,000 women on elective gynaecology waitlists and 378,188 patients on routine urology lists across England. Patients face diagnostic delays averaging 9 years and 4 months, extending to 11 years for ethnically diverse communities. Lacking structural workplace support during these extended wait periods, patients experience physical deterioration, driving frequent repeat GP consultations and non-elective emergency acute presentations. This severely strains NHS acute care while contributing to a £20.2 billion national economic burden. 

Founder story

Farirai Gora, a biochemistry graduate with over 13 years of experience in insurance regulatory and technology transformation, founded We Are Eden after navigating severe dysmenorrhea in silence at work. Experiencing chronic pain without structural support exposed a systemic “fluency gap” where managers lacked the tools and confidence to handle reproductive health challenges.  

Organisations lacked the infrastructure to bridge the executive benefits vs junior staff member benefits gap, leading to high attrition.  

 She managed to inspire a team of 10 developers to build Policy Pulse, an automation tool for workplace reproductive governance, de-risking human capital.  

Fari isn’t an NHS staff member.  

The solution

Policy Pulse, developed by We Are Eden, is an automated health navigation and dispute prevention tool. We’re a designed as a B2B SaaS compliance engine and employee reproductive health platform. We address health inequities caused by rapidly evolving global workplace legislation. Translating complex reproductive health law into automated corporate governance, compliance, and real-time manager guardrails.  

Supporting 72 multi-gender reproductive and urological conditions across all life stages, Policy Pulse bridges the post-diagnostic pre-treatment waitlist gap which has grown in prevalence due to accurate at home test kits.  

We automate manual HR workflows through digital manager training and an AI-powered medico-legal companion. 

Impact

Actual Outcomes (Validated to Date) 

  • Operational Efficiency: Reduces corporate policy compliance turnaround from 1 year to 1 day, saving employers 1.5 full-time equivalent (FTE) staff in manual HR processing overhead.  
  • Retention & ROI: Supports up to 60% employee retention and generates a 3.6x gross ROI within six months of deployment.  
  • Grant Cost Offset: Secured £37,000 in corporate cloud credits (AWS/Google), ensuring £0 infrastructure costs are charged to public grant budgets.  

Expected Impacts (36-Month Trial Targets) 

  • Patient Reach: Direct intervention for 500 multi-gender patients across 72 reproductive and urological conditions navigating NHS waitlists.  
  • Clinical Efficacy: Targets a ≥25% reduction in Visual Analogue Scale (VAS) pain scores over a 6-month tracking window.  
  • NHS Demand Reduction: Projects a ≥30% reduction in repeat primary care GP visits and a ≥40% reduction in non-elective emergency acute care escalations.  
  • Economic Recovery: Aims for a ≥35% reduction in workplace absenteeism, tackling the £20.2 billion national productivity loss and preventing corporate talent attrition costs of £11,000–£75,000 per employee